Specialty code 174400000X · San Antonio, TX
NPI
1790774198
Since 2005
Specialty
Specialty code 174400000X
Code 174400000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
9480 Huebner Rd, Ste. 210
San Antonio, TX, 78240
Phone (210) 614-9595
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$582K
3,024 prescriptions
Company payments, 2025
$2,483
From 17 companies
Medicare prescription drug claims, 2024
In 2024, the drug Aneta A Schuenemeyer prescribed most often to Medicare patients was Alprazolam, with 281 prescriptions and refills. In total Aneta A Schuenemeyer wrote 3,024 Medicare prescriptions that cost $582K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-02-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Alprazolam Generic | 281 | 305 | 41 | $2,043 |
| Clonazepam Generic | 191 | 233 | 22 | $2,401 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 134 | 152 | 23 | $5,613 |
| Lamotrigine Generic | 127 | 240 | 29 | $1,139 |
| Trazodone Hcl Generic | 126 | 230 | 29 | $1,020 |
| Sertraline Hcl Generic | 101 | 149 | 14 | $535 |
| Lurasidone Hcl Generic | 90 | 92 | 11 | $9,446 |
| Duloxetine Hcl Generic | 88 | 142 | 16 | $1,379 |
| Mirtazapine Generic | 87 | 107 | 16 | $943 |
| Trintellix Vortioxetine Hydrobromide | 87 | 127 | 14 | $59K |
| Lisdexamfetamine Dimesylate Generic | 86 | 94 | 13 | $21K |
| Zolpidem Tartrate Generic | 86 | 119 | 15 | $489 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 82 | 102 | 14 | $4,412 |
| Gabapentin Generic | 82 | 100 | 15 | $758 |
| Fluoxetine Hcl Generic | 76 | 102 | 11 | $483 |
Brand drugs: 430 claims; generic drugs: 2,594 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aneta A Schuenemeyer $2,483 ($2,483 in general payments such as food, travel and fees) from 17 companies. The largest payer was Axsome Therapeutics, Inc. with $428.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 20 | $428 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 17 | $328 |
| Neurocrine BioSciences, Inc. NBIX | 13 | $327 |
| Janssen Pharmaceuticals, Inc JNJ | 8 | $223 |
| Almatica Pharma LLC | 9 | $179 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $168 |
| Teva Pharmaceuticals USA, Inc. TEVA | 9 | $159 |
| Collegium Pharmaceutical, Inc. COLL | 13 | $143 |
| Noven Therapeutics, LLC | 5 | $115 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $81.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.